Immune Fortifier
2
479
beginner
May 16, 2026
Overview
The Immune Fortifier is a beginner-friendly peptide stack designed to strengthen and modulate the immune system through two complementary pathways: thymic restoration and antimicrobial defense. This protocol pairs Thymosin Alpha-1, a naturally occurring thymic peptide responsible for immune cell maturation, with LL-37, a human cathelicidin antimicrobial peptide that serves as a first-line innate defense molecule. Thymosin Alpha-1 at 1500mcg twice per week enhances T-cell differentiation, promotes dendritic cell maturation, and modulates cytokine balance between Th1 and Th2 responses. Originally isolated from thymic tissue, this peptide has been extensively studied for its ability to restore immune competence in immunocompromised individuals and has regulatory approval in over 35 countries for hepatitis and as an immune adjuvant. LL-37 at 100mcg every other day provides broad-spectrum antimicrobial activity against bacteria, viruses, and fungi while also modulating inflammatory signaling to prevent excessive immune activation. The synergy between these peptides lies in their complementary mechanisms: Thymosin Alpha-1 strengthens adaptive immune surveillance and long-term immune memory, while LL-37 bolsters innate frontline defenses and barrier integrity. Together, they create a more robust and balanced immune response without overstimulation. Administer Thymosin Alpha-1 subcutaneously on fixed days (e.g., Monday and Thursday). LL-37 is taken every other day, ideally in the morning. Both peptides are well-tolerated with minimal reported side effects, making this an excellent entry point for those new to peptide protocols. This stack is ideal for individuals with frequent infections, seasonal immune challenges, those recovering from illness, or anyone seeking proactive immune system maintenance. Research supports Thymosin Alpha-1 as a potent immunomodulator in clinical settings, while LL-37 studies demonstrate its role in wound healing, biofilm disruption, and mucosal immunity. A standard protocol runs 4-8 weeks with reassessment.
Dosing Protocol
Thymosin Alpha-1
Twice per week
1,500 mcg
per dose
LL-37
Every other day
100 mcg
per dose
Goals & Evidence
Disclaimer: This stack is community-submitted and for research purposes only. PeptideVault does not verify the safety or efficacy of submitted stacks. Always consult a qualified healthcare professional before using any peptide protocol.